共 306 条
[41]
Gangadhar TC(2017)Immunogenic cell death in cancer and infectious disease Nat Rev Immunol 14 12281-E4050
[42]
Vonderheide RH(2020)What went wrong with anticancer nanomedicine design and how to make it right ACS Nano 327 186-610
[43]
Matsumura Y(2020)Optimizing the anti-tumor efficacy of protein-drug conjugates by engineering the molecular size and half-life J Control Release 23 1011-824
[44]
Maeda H(2005)Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 19 566-654
[45]
Cao G(2020)The entry of nanoparticles into solid tumours Nat Mater 14 3075-undefined
[46]
Cao W(2020)Meta-Analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach ACS Nano 7 653-undefined
[47]
Zhang J(2010)Delivering nanomedicine to solid tumors Nat Rev Clin Oncol 153 198-undefined
[48]
Chen Q(2011)Targeted drug delivery to tumors: myths, reality and possibility J Control Release 4 1673-undefined
[49]
Chen J(2013)Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin Nat Commun 14 279-undefined
[50]
Chu Q(2019)Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness Nat Nanotechnol 115 E4041-undefined